Enzymatic DNA synthesis is a well-established technique of DNA synthesis that is useful in synthetic biology, genetic engineering, therapeutic antibodies, vaccine design, and other advanced biological techniques. It is also very helpful to maintain the DNA library and custom DNA synthesis. Major factors driving the market growth include the rising prevalence of genetic disorders and the surging number of product launches. Additionally, growing demand for personalized medicine and DNA data storage is likely to emerge as a significant future trend in the market during the forecast period.

 

The enzymatic DNA synthesis market is comprised of top players involving Telesis Bio Inc; Evonetix; Ansa Biotechnologies, Inc.; Camena Bio; GenScript Biotech Corp.; Molecular Assemblies; DNA Script; Touchlight; Synbio Technologies; and Twist Bioscience; and others. The companies have been implementing various strategies that have helped their growth and, in turn, brought about several breakthroughs and transitions in the industry. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the market players have also deployed several utilized inorganic strategies, including mergers & acquisitions, partnerships, and collaborations.

 

Read More: https://www.theinsightpartners.com/reports/enzymatic-dna-synthesis-market